Evommune, Inc. (EVMN)
20.74
+0.25
(+1.22%)
USD |
NYSE |
Jun 11, 13:33
Evommune EPS Diluted (Quarterly) : -0.6437 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.6437 |
| December 31, 2025 | -0.8969 |
| September 30, 2025 | -0.3957 |
| June 30, 2025 | -0.451 |
| Date | Value |
|---|---|
| March 31, 2025 | -0.484 |
| September 30, 2024 | -0.5049 |
| June 30, 2024 | -0.9104 |
| March 31, 2024 | -0.0926 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Apogee Therapeutics, Inc. | -1.064 |
| Kymera Therapeutics, Inc. | -0.7098 |
| Mineralys Therapeutics, Inc. | -0.4749 |
| GRAIL, Inc. | -2.293 |
| MapLight Therapeutics, Inc. | -1.342 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.67M |
| Total Expenses (Quarterly) | 21.67M |
| Enterprise Value | 535.67M |
| Earnings Yield | -11.51% |
| Normalized Earnings Yield | -12.53 |